These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20521362)

  • 21. Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure.
    Kasai-Brunswick TH; Costa AR; Barbosa RA; Farjun B; Mesquita FC; Silva Dos Santos D; Ramos IP; Suhett G; Brasil GV; Cunha ST; Brito JO; Passipieri JD; Carvalho AB; Campos de Carvalho AC
    Stem Cell Res Ther; 2017 Feb; 8(1):36. PubMed ID: 28202059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetazolamide may provoke cyclosporine toxicity-a case report.
    Ruokoniemi P; Tertti R; Paalosmaa-Puusa P; Kareranta H; Laine K
    NDT Plus; 2009 Aug; 2(4):298-9. PubMed ID: 25984020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
    Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ
    Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
    [No Abstract]   [Full Text] [Related]  

  • 24. [Success of cyclosporine therapy in two patients with PSS].
    Higuchi C; Sanaka T; Nihei H; Sugino N
    Ryumachi; 1993 Jun; 33(3):242-8. PubMed ID: 8346467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubility Studies of Cyclosporine Using Ionic Liquids.
    Berton P; Mishra MK; Choudhary H; Myerson AS; Rogers RD
    ACS Omega; 2019 May; 4(5):7938-7943. PubMed ID: 31459882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Drug-drug Interaction Between Cyclosporine and Nystatin.
    Liu W; Guan X; Yu Z; Chen K; Benet L; Zhai S
    Clin Ther; 2018 Apr; 40(4):660-662. PubMed ID: 29551534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperpigmentation Due to Cyclosporine Therapy.
    Sharma AN; Dobry AS; Linden K
    Cureus; 2019 Feb; 11(2):e4072. PubMed ID: 31019850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum cyclosporine levels in patients after kidney transplantation].
    Karamehić J; Ascerić M; Tulumović T; Uzeirbegović M; Hadzibegić N
    Med Arh; 1998; 52(3):131-2. PubMed ID: 9863315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.
    Bilbao I; Parrilla P; Rimola A; Figueras J; Fabrega E; Gomez M; De Vicente E; Margarit C
    Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300
    [No Abstract]   [Full Text] [Related]  

  • 30. Digoxin-cyclosporine interaction: severe digitalis toxicity after cyclosporine treatment.
    Dorian P; Strauss M; Cardella C; David T; East S; Ogilvie R
    Clin Invest Med; 1988 Apr; 11(2):108-12. PubMed ID: 3396255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine nephrotoxicity.
    Burdmann EA; Andoh TF; Yu L; Bennett WM
    Semin Nephrol; 2003 Sep; 23(5):465-76. PubMed ID: 13680536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine treatment for dermatomyositis/polymyositis.
    Mehregan DR; Su WP
    Cutis; 1993 Jan; 51(1):59-61. PubMed ID: 8419114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The kinetics of cyclosporine and its metabolites in bone marrow transplant patients.
    Schwinghammer TL; Przepiorka D; Venkataramanan R; Wang CP; Burckart GJ; Rosenfeld CS; Shadduck RK
    Br J Clin Pharmacol; 1991 Sep; 32(3):323-8. PubMed ID: 1777368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psoriasis and cyclosporine: an attempt at topical treatment].
    Gajardo J; Villaseca J
    Rev Med Chil; 1994 Dec; 122(12):1404-7. PubMed ID: 7659916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hierba del clavo (Geum chiloense) modifying cyclosporine levels: potential risk for transplanted people].
    Duclos J; Goecke H
    Rev Med Chil; 2001 Jul; 129(7):789-90. PubMed ID: 11552449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe central nervous system toxicity after chronic treatment with cyclosporine.
    García-Escrig M; Martinez J; Fernandez-Ponsatí J; Diaz J; Soto O
    Clin Neuropharmacol; 1994 Jun; 17(3):298-302. PubMed ID: 9316676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for pre-hepatic metabolism of oral cyclosporine in children.
    Hoppu K; Koskimies O; Holmberg C; Hirvisalo EL
    Br J Clin Pharmacol; 1991 Oct; 32(4):477-81. PubMed ID: 1958443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rebound effect of the allogenic T-cell response to donor and third-party lymphocytes after cyclosporine withdrawal in renal transplant recipients.
    Creemers P; Pascoe MD; Pontin AR; Kahn D
    Transpl Immunol; 1998 Dec; 6(4):261-4. PubMed ID: 10342740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver regeneration after orthotopic reduced-size hepatic transplantation in the rat.
    Kikuchi N; Yamaguchi Y; Mori K; Takata N; Goto M; Makino Y; Hamaguchi H; Hisama N; Ogawa M
    Hepatogastroenterology; 1994 Apr; 41(2):170-3. PubMed ID: 8056408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine therapeutic and toxic effects may be related to different cyclosporine concentration zones in plasma.
    Wu G; Yan SM
    Med Hypotheses; 2001 May; 56(5):691-2. PubMed ID: 11388789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.